COSMOS HEALTH NEW DL-01 - Asset Resilience Ratio
COSMOS HEALTH NEW DL-01 (V67A) has an Asset Resilience Ratio of 0.07% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2025)
This chart shows how COSMOS HEALTH NEW DL-01's Asset Resilience Ratio has changed over time. See COSMOS HEALTH NEW DL-01 (V67A) flexibility index to measure the company's free cash flow as a share of total liabilities.
Liquid Assets Composition Over Time
This chart breaks down COSMOS HEALTH NEW DL-01's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see V67A stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €46.16K | 0.07% |
| Total Liquid Assets | €46.16K | 0.07% |
Asset Resilience Insights
- Limited Liquidity: COSMOS HEALTH NEW DL-01 maintains only 0.07% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
COSMOS HEALTH NEW DL-01 Industry Peers by Asset Resilience Ratio
Compare COSMOS HEALTH NEW DL-01's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
China National Medicines Corp Ltd
SHG:600511 |
Medical Distribution | 0.04% |
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368 |
Medical Distribution | 1.77% |
|
TELES Informationstechnologien AG
XETRA:TLIK |
Medical Distribution | 0.37% |
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Cyclopharm Ltd
AU:CYC |
Medical Distribution | 1.98% |
Annual Asset Resilience Ratio for COSMOS HEALTH NEW DL-01 (2021–2025)
The table below shows the annual Asset Resilience Ratio data for COSMOS HEALTH NEW DL-01.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.07% | €46.16K ≈ $53.96K |
€65.48 Million ≈ $76.55 Million |
+0.03pp |
| 2024-12-31 | 0.04% | €21.15K ≈ $24.72K |
€54.31 Million ≈ $63.50 Million |
+0.01pp |
| 2023-12-31 | 0.03% | €20.07K ≈ $23.47K |
€66.01 Million ≈ $77.18 Million |
+0.01pp |
| 2022-12-31 | 0.02% | €14.88K ≈ $17.40K |
€68.04 Million ≈ $79.54 Million |
0.00pp |
| 2021-12-31 | 0.02% | €11.47K ≈ $13.41K |
€49.43 Million ≈ $57.79 Million |
-- |
About COSMOS HEALTH NEW DL-01
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It als… Read more